NCT00719966View on ClinicalTrials.gov

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

September 18, 2008

Primary Completion Date

June 13, 2013

Study Completion Date

January 24, 2020

Conditions
Breast Cancer
Interventions
DRUG

anastrozole

Patients receive aromatase inhibition therapy.

DRUG

exemestane

Patients receive aromatase inhibition therapy.

DRUG

letrozole

Patients receive aromatase inhibition therapy.

PROCEDURE

assessment of therapy complications

Endothelial function is measured

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER